chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have not been able to conceive since I received the Pfizer vaccine; my period didn't start when it was supposed to; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Feb2022 as dose 1, single (Lot number: FK9896) at the age of 36 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Mucinex, reaction(s): "Known allergies: Mucinex". The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 17Feb2022, outcome "not recovered", described as "my period didn't start when it was supposed to"; INFERTILITY FEMALE (non-serious), outcome "not recovered", described as "I have not been able to conceive since I received the Pfizer vaccine". The events "my period didn't start when it was supposed to" and "i have not been able to conceive since i received the pfizer vaccine" required physician office visit.  Additional information: It was reported that after 1st dose, patient period didn't start when it was supposed to. Patient have not been able to conceive since she received the Pfizer vaccine. Patient did not had problems with her menstruation before Feb2022. Patient had covid prior vaccination. Covid was not tested positive post vaccination. Patient did not received other vaccine in four weeks.
Began having headache for an entire week and on 11/23/2022 began hurting all over and headache got worse. Also began having unquenchable thirst and just felt dry. Went to urgent care on 11/25/2022. Tested negative for COVID-19, flu, and strep. Urgent care put me on antibiotic and steroid. Also experienced sore throat, congestion, and cough intermittently. Also used OTC sinus meds and TYLENOL for congestion and achiness. Some days I can't taste foods and somedays I can. Still experiencing insomnia.
got the shot 3 days later he was dead; This case was reported by a consumer via media and described the occurrence of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the death was fatal. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the death to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The case was reported by reporter for a friend's husband. The patient was in perfect shape but passed away 3 days after his shingles shot.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR131309:Same reporter.; Reported Cause(s) of Death: Unknown cause of death
Pt. had adverse RXN to PCV Pt. requested PCV. Pt. received .05 ml on 3/3/09 in (R) arm no RXN @ time of shot. Pt called on 3/4/09 (advised to come see Dr. on 3/4/09. Pt denied care & showed up on 3/5/09. Pt had erythremia & edema. Pt fever was 99.8 degrees fever. Dr treated accordingly. *Pt instructed on 3/4/09 to ice site & take TYLENOL.
Information has been received from a physician referring to a female patient of unknown age. On an unknown date (reported as "a couple of years ago") the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date, dose and route were not provided). On an unknown date the patient experienced ophthalmic shingles. The patient sought medical attention by saw physician. The outcome of event was resolved on an unknown date. Additional information has been requested.
Nurse cautioned that some people have a reaction to the second does and to minimize the reaction I could take a tylenol in 6 hours. I had my shot at 8:55 am, so I took a 325 mg tylenol at 3 pm on the day of my shot. My arm got sore but not too bad. I went to bed at my regular time of 10 pm. I woke up at 1 am on Saturday. I was shaking from chills, my teeth hurt from my teeth chattering. I could not get warm. I got up and checked the thermostat to see if I needed to turn up the heat, it was 74 degrees. I checked my temperature it was only 99. 6 degrees. I went and got another blanket and it took another 3 hours for my shaking to quit. I didn't sleep the rest of the night I was too hot or too cold.  I finally gave up and got dressed at 6 am. The rest of day I was running a low grade fever. My jaws hurt from all the chattering they did earlier. I had a headache bordering on a migraine all day.  I took a short nap but still felt drugged out. I couldn't think good. I was physically hot to the touch but still just had a low grade fever. I went to bed early at 9 pm. I took two antihistamine in order to sleep. I woke up at 6 am this morning. The fever had broken,, all my clothes were wet, I had to chang them. I fell much better this morning.
Covid 19 positive after getting vaccine; A spontaneous report was received from a consumer concerning a 64-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for COVID-19 Virus.   The patient's medical history was not provided by the reporter. Concomitant medications reported included ESOMEPRAZOLE, LISINOPRIL, METOPROLOL, ATORVASTATIN, 83MG BABY ASPIRIN, VITAMIN D3, VITAMIN C with ZINC.   On 12 Jan 2021, prior to the onset of the event, the patient received the first of two planned doses of mRNA-1273 (Lot number: 025L20A) for prophylaxis of COVID-19 infection.   On 13 Jan 2021, after receiving mRNA-1273, the patient tested positive for COVID-19 Virus. Treatment for the event is unknown at this time.  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of the event Positive COVID-19, was considered to be unknown at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
administration error only, no side effects Moderna was inadvertently given by Nurse instead of Pfizer and the child is only 14 years of age   she was educated about the vaccine that was given, provided materials, kept for monitoring for 30 minutes. provided with public health nurse contact info. no adverse reaction observed, reported, or noted aside from minor redness at injection site after 30 minutes. child was released home with grandmother who is her legal guardian. Contacted department of health who advised us to complete this vaers report but to go ahead and have them come back for her second dose of moderna after 28 days
Patient complained of facial numbness and tingling on left side of face, nausea, flushes, and chills.
noticed in her scalp, little raised bumps; welts breaking out on her neck/welts went down to the area between her breasts; rash is still present and it itches now sometimes; rash is still present and it itches now sometimes; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration in arm left, on 12May2021 (age at vaccination: 63 years), as a dose 2, single for COVID-19 immunization. The patient's medical history includes sick with flu like symptoms and ongoing diabetes. The patient concomitant medications were not reported. It was reported that in the past she travelled to Africa and received many vaccines that the CDC recommended. One of them made her sick with flu like symptoms. It was reported that the patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration in arm left, on an unspecified date, as a dose 1, single for COVID-19 immunization. On 14May2021, two days later she started to notice in her scalp, little raised bumps. They didn't itch but she noticed them. On her neck area, might be a rash but looks like welts breaking out on her neck and down into the area between her breasts. The patient queried if this was a side effect. The patient stated that nothing new has changed as far as her routines or her medications. The rash was still present, and it itches now sometimes. Reportedly the patient showed it to the pharmacist, and he told her to take Benadryl and Hydrocortisone. She's been doing that since last Thursday. Relevant Tests was None. The patient did not Emergency Room and Physician Office. Outcome of the event was not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
This spontaneous report as received from a 79 years old female consumer refers to herself with no pertinent history and no drug reactions or allergies. On 09-JAN-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) for prevention of shingles. Concomitant medications included lisinopril, JANUVIA and meclizine. On 09-JAN-2012 after receiving ZOSTAVAX, the patient's face became swollen and she developed a rash. The rash has persisted since the date of administration of ZOSTAVAX. Treatment with BENADRYL was given for the events. No lab diagnostic studies were performed. The patient sought unspecified medical attention. The outcome of the events was reported as not recovered. The relatedness for the events was unknown for the vaccination. Additional information has been requested.
felt faint & looked pale for 15-30min;about 30min of  ante grade amnesia, very tired & listless & dizzy next day;
Felt like I had Covid19 all over again. 30 hours of misery! Bad body aches, chills all night,  lining of skull and back of neck going into the head felt warm, feverish. Inner ear ached, back of eyeballs ached, joints ached badly. Tylenol lessened the pain somewhat, but didn't get rid of it. Had sharp pain in heart during the night. No position in bed helped, neither did walking around until I went back to bed and laid down on my stomach. Pain then subsided and didn't come back.  Was headachy for 3 days after the injection.
Per patient report, site of vaccine became painful in evening. Patient went to hospital next day due to pain, swelling, and slight numbness. Patient was reportedly admitted and treated for cellulitis.
Interior lower left leg above ankle swollen with a very large, hot, tender knot.  Hot pack elevated
Severe headache and fatigue after Pfizer vaccine. Unable to work for several days. Seen by PCP and treated for sinus infection.
BM movements stopped except for a few small of amount of what looked like tarry mucus wrapped rabbit pellets. A long with that began losing intestinal lining, drops out in chucks or pools of mucous sticky stuff. This has been going on since about 8 hours from getting the shot and has not stop since. It leaks out so much I have to wear a adult diaper. Not happy about that at all. I am hoping this side effect will cease soon I need the lining in my guts not on the floor. Also had the chills in days following shot and dry cough and felt very tired.
Bell's palsy; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (Bell's palsy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced BELL'S PALSY (Bell's palsy) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (Bell's palsy) had not resolved. Not Provided          No concomitant products were reported. No treatment drugs were reported  patient have a question regarding booster dose, patient felt it was dangerous thing to takewhich might leads to moebius syndrome.  Company comment: This case concerns a male patient of an unknown age with no relevant medical history, who experienced the unexpected adverse event of special interest of Bells' Palsy. The event occurred approximately the same month after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a male patient of an unknown age with no relevant medical history, who experienced the unexpected adverse event of special interest of Bells' Palsy. The event occurred approximately the same month after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
I had the shot and also have had two cases of shingles/ suspected vaccination failure; I had the shot and also have had two cases of shingles.; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but selected as adult as per the vaccine indication. The patient received a shot of Shingles vaccine and had two cases of shingles. This case was considered as suspected vaccination failure as details regarding the vaccination schedule, laboratory test confiding shingles and time to onset for shingles were unknown at the time of reporting.
SOB 12hr post immun, also h/a;pt may have had other h/a p/other vax;
PAIN OF EXTREMITIES; This spontaneous report received from a patient. The patient's past medical history included numbness in hand, and pain in fingers, and concurrent conditions included osteoarthritis, no tobacco use, knee pain on and off, skin discoloration, sleep unwell, pain, paresthesia of fingers, psoriasis flare-up, bone pain, and skin breakout.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 041A24A, and expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. Concomitant medications included adalimumab for psoriatic arthritis, and rheumatoid arthritis. On 2021, the subject experienced pain of extremities. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain of extremities. This report was non-serious..
Arm they put it on, it is itchy and red; Arm they put it on, it is itchy and red; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: unspecified, Pfizer NTEC), via an unspecified route of administration in arm on 02Feb2021 as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: unspecified, Pfizer NTEC), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. On an unspecified date the patient stated that, the arm they put it on, it was itchy and red. The patient further stated that with the first dose patient didn't have any problem but second dose they gave caused itching around it and kind of redness just a little bit, not big deal. The clinical outcome for the event was unknown.  Information on lot/batch number has been requested.
14 year old female had Covid vaccine 8 months prior to the start of arrhythmia and syncopal episodes and seizures.
Cyst/mass around her pancreas region after second dose; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of CYST (Cyst/mass around her pancreas region after second dose) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CYST (Cyst/mass around her pancreas region after second dose). At the time of the report, CYST (Cyst/mass around her pancreas region after second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications was provided by the reporter.  No Treatment medications was provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up added and updated patient contact details(Email and Fax).
DIZZY, FELL ON HER HEAD, CALLED 911, PT WAS RESPONSIVE AFTER SHE FELL, CHECKED PULSE WAS OK, PARAMEDIC CHECKED VITAL BLOOD PRESSURE WAS CHANGING WITH POSTURE, MAY BE DEHYDRATED, PT WENT HOME OK AFTER 20 MIN CALLED AND FOLLLOWED UP AFTER 1 HOURS SHE WAS DOING OK.
patient received dose of Moderna vaccine post excursion; patient received dose of Moderna vaccine post excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (patient received dose of Moderna vaccine post excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (patient received dose of Moderna vaccine post excursion).    Concomitant product use was not provided by the reporter.  It was reported that patient received the bivalent dose of Moderna vaccine post excursion.  Treatment information was not provided.  This case contains information for the 15th of 19 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-706941 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-706941:Patient 1 of 19
After receiving injections, patient complained of stomach ache and feeling lightheaded, sat on floor at check out counter, then color changed, paler and became less responsive, carried to exam room.  Layed down, legs lifted, 02 99%, pulse 60, B/P 120/68 at 4pm.  Rev 10 mins, O2 100%, pulse 74 lay, sat up 80, stand 85.  With patient say felt better, sent home.
hives approximately 5 hours later; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (hives approximately 5 hours later) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives approximately 5 hours later). At the time of the report, URTICARIA (hives approximately 5 hours later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter. No treatment information was provided.
He developed very labored breathing on Tuesday night.  By Wednesday morning , upon waking it was severly worse.  I would have taken him to the ER had I been home.  When I returned home around 11am, he was having a very hard time breathing.  I got him a rescue inhaler to use.  He had a dailysis treatment that day, during the treatment they kept him on oxygen.  I called Dr office to inform them, they ordered a new inhaler and told me if the symptoms did not decrease by 72 hours to inform them.  His breathing did get somewhat better but he did not have his enegry levels that he had previously or his appeatite.  12 days after his 2nd dose of the Moderna vaccine he went into cardiac arrest in the home with myself and husband present.
Breakthrough case admission after two vaccines Moderna 4/2/21 Lot# 017B21A;  Moderna 5/3/21 Lot# 006C21A
severe headache, 104.1 fever, high heart rate (160)  treatment: IV, ketorolac discharged from ER after 4 hours
red area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red area at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 36821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area at the injection site). On 18-Mar-2021, VACCINATION SITE ERYTHEMA (red area at the injection site) had resolved. Not Provided          Concomitant medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-077804 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077804:CROSSLINKED WITH DOSE 2
Dizziness, palpitations, racing heart. BP 145/82 (pulse 71), 100% O2 sat. Snack and oral fluids given. BP 123/59 (pulse 66), 100% O2 sat.